Individuals portrayed on this site are actors.
PAXLOVID is a prescription treatment for mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
Who can take PAXLOVID?
As much as we all wish COVID‑19 were a thing of the past, it’s not. It’s still very much here and making some people very sick, especially people who are at high risk for progression to severe COVID‑19.
PAXLOVID is an FDA-approved oral prescription medication that can treat adults who:
PAXLOVID is not approved for use as pre-exposure or post-exposure treatment for prevention of COVID‑19. There are certain medications that should not be taken with PAXLOVID. Talk to your healthcare professional to see if PAXLOVID is right for you.
Approximately 75% of American adults have at least one risk factor for progression to severe COVID‑19. You could be one of them.
Some of the most common risk factors for progression to severe COVID‑19 include:
- Age of 50+ years
- Certain health conditions and diseases, such as heart disease and diabetes
- Being overweight or obese
- Mental health conditions
- Lifestyle factors, such as smoking
- Physical, mental, and developmental disabilities
You may be able to access PAXLOVID for as little as $0.*
Eligible commercially insured patients may access PAXLOVID for as little as $0* and if not commercially insured, for free.†
*Eligible commercially insured patients can save up to $1,500 per prescription. Maximum annual savings up to $1,500. Terms and conditions apply. Full terms and conditions for the Co-Pay Program may be found here.
†The U.S. Government Patient Assistance Program (USG PAP) operated by Pfizer provides patients on Medicare, Medicaid, TRICARE, VA Community Care Network, and those who are uninsured access to PAXLOVID for free through December 31, 2024. The USG PAP operated by Pfizer is an independent program with separate eligibility requirements offered by the United States Department of Health and Human Services and is not owned by Pfizer. Full terms and conditions apply. Please visit www.PAXLOVID.com/usg-terms-and-conditions for full terms and conditions.
Want to learn more about PAXLOVID?
PAXLOVID is a 5-day oral prescription treatment for COVID‑19.
A trial compared the risk of COVID‑19–related hospitalization or death in people treated with PAXLOVID vs placebo.
It’s important to understand the risks and possible side effects of PAXLOVID before starting treatment.
How to verify your tablets are authentic
PAXLOVID must be prescribed by a licensed healthcare professional and supplied by a government-approved pharmacy or medical facility.
Authentic PAXLOVID, from Pfizer Inc., will include the Pfizer name on the label and will be packaged in several aluminum push-through blister cards. Individual doses are not for sale. PAXLOVID will be packaged in a carton. The carton has a colorless, glossy coating that contains a repeated pattern of the Pfizer name and logo all over, and these repeating features are seen in a contrasting matte finish.
PAXLOVID consists of tablets for a 5-day oral treatment regimen, with morning and evening doses.
NOTE: If you are a patient with moderate-to-severe renal impairment, you may receive a carton with daily blister cards that have been modified to ensure you receive the correct dose.
To help determine whether the tablets are authentic, look for specific text on each side of the tablets
For packaging options and information, see the Patient PAXLOVID Packaging Flashcard here.
Pfizer is committed to patient safety and ensuring that people have accurate information about PAXLOVID, including how it is accessed and administered. We are actively monitoring for fraudulent offers of illegitimate PAXLOVID to protect patients from products that might be dangerous and lead to serious and life-threatening harm.
If you suspect the product you have received may be counterfeit, contact us at 1-800-438-1985 or visit www.pfizersafetyreporting.com.
For more information
Contact one of the following groups:
For medical information visit www.pfizermedicalinformation.com or call 1-800-438-1985
For general product inquiries call 1‑877‑C19‑PACK (1-877-219-7225)